tirzepatide effect on sleep Original Article: for the Treatment of Obstructive Apnea and Obesity (SURMOUNT-OSA) buff.ly/4ccuPKO Editorial: Entering a New Era in Sleep-Apnea Treatment buff.ly/3XyX1D2 How Tirzepatide Helps Treat Sleep

Promise and Popularity Of the drugs that are currently approved in the United States for the treatment of obesity or overweight, the GLP-1 receptor agonists are the only class with demonstrated evidence for decreasing the risk of ASCVD by altering the vasculature endothelium, reducing oxidative stress, and increasing nitric oxide production in addition to lowering blood glucose, Hurtado Andrade noted

The NovoCare savings card can bring eligible commercially-insured patients to $0 to $25 per month (Medicare patients are not eligible)

"Since starting my GLP-1 treatment, I feel lighter, more energized, and more in control of my health than ever before

10.1016/j.expneurol.2024.115084 103 WangS

Metabolic and Endocrine Risks Hypoglycemia (CRITICAL RISK): The most serious acute risk is low blood sugar